role for T cell-derived interleukin 22 in psoriatic skin inflammation

Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental immunology Vol. 150; no. 3; pp. 407 - 415
Main Authors Boniface, K, Guignouard, E, Pedretti, N, Garcia, M, Delwail, A, Bernard, F.-X, Nau, F, Guillet, G, Dagregorio, G, Yssel, H, Lecron, J.-C, Morel, F
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.12.2007
Blackwell Publishing Ltd
Blackwell
Wiley
Blackwell Science Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-22R1) in skin lesions, skin-derived T cells, as well as IL-22 levels in sera from patients with psoriasis. IL-22R1 and IL-10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL-22 mRNA expression was up-regulated in psoriatic skin lesions compared to normal skin, whereas IL-22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL-22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL-22 in comparison to peripheral T cells isolated from the same patients. IL-10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin-infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL-22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis.
AbstractList Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-22R1) in skin lesions, skin-derived T cells, as well as IL-22 levels in sera from patients with psoriasis. IL-22R1 and IL-10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL-22 mRNA expression was up-regulated in psoriatic skin lesions compared to normal skin, whereas IL-22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL-22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL-22 in comparison to peripheral T cells isolated from the same patients. IL-10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin-infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL-22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis.
Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-22R1) in skin lesions, skin-derived T cells, as well as IL-22 levels in sera from patients with psoriasis. IL-22R1 and IL-10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL-22 mRNA expression was up-regulated in psoriatic skin lesions compared to normal skin, whereas IL-22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL-22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL-22 in comparison to peripheral T cells isolated from the same patients. IL-10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin-infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL-22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis.Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-22R1) in skin lesions, skin-derived T cells, as well as IL-22 levels in sera from patients with psoriasis. IL-22R1 and IL-10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL-22 mRNA expression was up-regulated in psoriatic skin lesions compared to normal skin, whereas IL-22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL-22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL-22 in comparison to peripheral T cells isolated from the same patients. IL-10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin-infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL-22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis.
Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-22R1) in skin lesions, skin-derived T cells, as well as IL-22 levels in sera from patients with psoriasis. IL-22R1 and IL-10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL-22 mRNA expression was up-regulated in psoriatic skin lesions compared to normal skin, whereas IL-22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL-22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL-22 in comparison to peripheral T cells isolated from the same patients. IL-10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin-infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL-22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis.
Summary Interleukin (IL)‐22 is a T cell‐derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory‐like phenotype. In the present study, we assessed the presence of IL‐22 and the IL‐22 receptor 1 (IL‐22R1) in skin lesions, skin‐derived T cells, as well as IL‐22 levels in sera from patients with psoriasis. IL‐22R1 and IL‐10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL‐22 mRNA expression was up‐regulated in psoriatic skin lesions compared to normal skin, whereas IL‐22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL‐22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL‐22 in comparison to peripheral T cells isolated from the same patients. IL‐10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin‐infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL‐22 is a cytokine produced by skin‐infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis.
Author Delwail, A
Garcia, M
Dagregorio, G
Boniface, K
Nau, F
Yssel, H
Lecron, J.-C
Guillet, G
Guignouard, E
Bernard, F.-X
Morel, F
Pedretti, N
Author_xml – sequence: 1
  fullname: Boniface, K
– sequence: 2
  fullname: Guignouard, E
– sequence: 3
  fullname: Pedretti, N
– sequence: 4
  fullname: Garcia, M
– sequence: 5
  fullname: Delwail, A
– sequence: 6
  fullname: Bernard, F.-X
– sequence: 7
  fullname: Nau, F
– sequence: 8
  fullname: Guillet, G
– sequence: 9
  fullname: Dagregorio, G
– sequence: 10
  fullname: Yssel, H
– sequence: 11
  fullname: Lecron, J.-C
– sequence: 12
  fullname: Morel, F
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19869088$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17900301$$D View this record in MEDLINE/PubMed
https://univ-poitiers.hal.science/hal-01705160$$DView record in HAL
BookMark eNqNUk1v1DAQtVAR3Rb-AuQCEoeEGSd24gOVqtX2Q1qJA-3Zchyn9ZKNFzu7tP8ep7tsoZfFB3-M33vjGb8TctS73hCSIGQYx5dFhjlnKaWFyChAmUHOELOHV2SyvzgiEwAQqUAojslJCIt45JzTN-QYSwGQA07IzLvOJK3zyU2iTdeljfF2Y5rE9oPxnVn_sH1CaTwmq-C8VYPVSRiDtm87tVzGgOvfktet6oJ5t1tPye3F7GZ6lc6_XV5Pz-ep5pRiygQabZDnDbJa1Ni0qqhL5Ew1FXLVMKVAVwU2hhemRsFK0WpamJbFWRvIT8nZVne1rpem0aYfvOrkytul8o_SKSv_ventvbxzGxmzi7zMo8DnrcD9C9rV-VyOMcASGHLYYMR-2iXz7ufahEEubRh7pHrj1kHyikFOGT8ILMpCIKfiIJACA1ryIgLf_13n_qV__i0CPu4AKmjVtV712oZnnKi4gKp6bpj2LgRvWqnt8PRlsT22kwhyNJRcyNE3cvSNHA0lnwwlH6JA9UJgn-Mw9euW-st25vG_eXI6ux53kf9hy2-Vk-rOx_puv9NYPEBFGVZF_hsPL-ng
CODEN CEXIAL
CitedBy_id crossref_primary_10_1016_j_sder_2010_03_001
crossref_primary_10_1016_j_jff_2021_104352
crossref_primary_10_1371_journal_pone_0140750
crossref_primary_10_1371_journal_pcbi_1001024
crossref_primary_10_3390_ijms21093303
crossref_primary_10_4049_jimmunol_1000847
crossref_primary_10_2177_jsci_34_13
crossref_primary_10_1016_j_cytogfr_2010_10_007
crossref_primary_10_1111_jgh_13537
crossref_primary_10_1155_2014_182549
crossref_primary_10_1189_JLB_0109046
crossref_primary_10_3390_ijms20071670
crossref_primary_10_1038_jid_2009_59
crossref_primary_10_1074_jbc_M114_573071
crossref_primary_10_1186_ar4317
crossref_primary_10_1016_j_humimm_2024_110814
crossref_primary_10_1016_j_intimp_2015_11_005
crossref_primary_10_1002_cti2_1017
crossref_primary_10_1016_j_febslet_2009_03_006
crossref_primary_10_4049_jimmunol_0902464
crossref_primary_10_1007_s10875_008_9233_0
crossref_primary_10_1172_jci_insight_86434
crossref_primary_10_1155_2013_856056
crossref_primary_10_1002_hep_26528
crossref_primary_10_1016_j_jprot_2016_03_040
crossref_primary_10_1016_j_cyto_2013_08_005
crossref_primary_10_1038_s41598_019_43899_9
crossref_primary_10_1016_j_cyto_2024_156617
crossref_primary_10_1016_j_trsl_2019_10_004
crossref_primary_10_1517_14728222_2013_838220
crossref_primary_10_1016_j_immuni_2011_08_001
crossref_primary_10_4049_jimmunol_1001001
crossref_primary_10_3389_fimmu_2021_584414
crossref_primary_10_5021_ad_2016_28_5_579
crossref_primary_10_1038_ni_3742
crossref_primary_10_1111_jocd_13779
crossref_primary_10_1056_NEJMe1201071
crossref_primary_10_4049_jimmunol_1000824
crossref_primary_10_1002_eji_201041131
crossref_primary_10_1101_cshperspect_a028548
crossref_primary_10_1016_j_bmcl_2015_03_025
crossref_primary_10_1196_annals_1443_021
crossref_primary_10_1177_1721727X1301100303
crossref_primary_10_1586_1744666X_2014_884461
crossref_primary_10_1016_j_biopha_2017_05_005
crossref_primary_10_1016_j_jdin_2022_08_008
crossref_primary_10_3390_life13051076
crossref_primary_10_1016_j_jaci_2018_09_032
crossref_primary_10_1016_j_clim_2009_11_008
crossref_primary_10_4049_jimmunol_1103173
crossref_primary_10_3390_v16030425
crossref_primary_10_1371_journal_pone_0062154
crossref_primary_10_1016_j_jdermsci_2013_04_028
crossref_primary_10_1016_j_bcp_2013_11_012
crossref_primary_10_1089_jir_2013_0099
crossref_primary_10_1002_art_38376
crossref_primary_10_1016_j_jep_2022_115275
crossref_primary_10_1177_1535370217710637
crossref_primary_10_1182_blood_2008_06_162420
crossref_primary_10_1111_j_1600_0536_2008_01454_x
crossref_primary_10_1007_s00018_020_03726_1
crossref_primary_10_1007_s10571_021_01153_9
crossref_primary_10_3390_cells10061392
crossref_primary_10_4049_jimmunol_1401244
crossref_primary_10_1111_bph_12196
crossref_primary_10_1016_j_jaci_2012_05_003
crossref_primary_10_1371_journal_pone_0018741
crossref_primary_10_1016_j_cellimm_2008_10_002
crossref_primary_10_1111_bjd_13236
crossref_primary_10_3389_fmolb_2023_1196323
crossref_primary_10_4049_jimmunol_181_12_8504
crossref_primary_10_1038_srep44172
crossref_primary_10_1038_s41598_018_23510_3
crossref_primary_10_1371_journal_pone_0182646
crossref_primary_10_1111_exd_14551
crossref_primary_10_1016_j_jaci_2009_03_041
crossref_primary_10_1007_s12026_022_09325_5
crossref_primary_10_1016_j_cytogfr_2010_08_001
crossref_primary_10_1371_journal_ppat_1001144
crossref_primary_10_1073_pnas_0911472106
crossref_primary_10_1111_ijd_12883
crossref_primary_10_1038_s41598_018_38156_4
crossref_primary_10_1016_j_jdermsci_2013_03_011
crossref_primary_10_1172_JCI40202
crossref_primary_10_1038_icb_2011_79
crossref_primary_10_3389_fimmu_2023_1081256
crossref_primary_10_1007_s00018_010_0380_0
crossref_primary_10_1016_j_immuni_2008_03_002
crossref_primary_10_1038_jid_2014_81
crossref_primary_10_1016_j_imbio_2013_05_005
crossref_primary_10_4049_jimmunol_0903907
crossref_primary_10_1038_s41598_025_90961_w
crossref_primary_10_1002_eji_201040878
crossref_primary_10_1182_blood_2010_01_263509
crossref_primary_10_1002_eji_201546070
crossref_primary_10_1016_j_cyto_2023_156293
crossref_primary_10_5005_jp_journals_10047_0015
crossref_primary_10_1038_jid_2011_486
crossref_primary_10_1517_14728222_2013_736497
crossref_primary_10_1016_j_cyto_2014_09_007
crossref_primary_10_3389_fmicb_2021_729053
crossref_primary_10_1016_j_ajpath_2012_12_007
crossref_primary_10_1016_j_heliyon_2022_e08729
crossref_primary_10_1074_jbc_M111_286492
crossref_primary_10_1517_14728210902771334
crossref_primary_10_1111_j_1346_8138_2011_01458_x
crossref_primary_10_1097_01_EWX_0000511083_73976_6f
crossref_primary_10_1016_j_jaci_2013_01_029
crossref_primary_10_1111_exd_13270
crossref_primary_10_1155_2016_4395276
crossref_primary_10_1038_s41598_017_01468_y
crossref_primary_10_1016_j_cyto_2013_03_013
crossref_primary_10_1016_j_jep_2020_112760
crossref_primary_10_1016_j_jaci_2010_07_041
crossref_primary_10_4110_in_2018_18_e42
crossref_primary_10_1002_eji_201445144
crossref_primary_10_1042_BSR20203130
crossref_primary_10_1172_JCI37378
crossref_primary_10_3390_app112411599
crossref_primary_10_1016_j_jid_2018_07_032
crossref_primary_10_3389_fimmu_2021_618110
crossref_primary_10_1111_j_1600_0625_2009_00840_x
crossref_primary_10_3389_fimmu_2017_00978
crossref_primary_10_4049_jimmunol_1102224
crossref_primary_10_1016_j_jaci_2015_01_033
crossref_primary_10_1002_eji_200939473
crossref_primary_10_1002_eji_201141958
crossref_primary_10_3892_mmr_2016_5108
crossref_primary_10_1007_s13277_016_5030_1
crossref_primary_10_2147_PTT_S335913
crossref_primary_10_3389_fimmu_2019_00589
crossref_primary_10_1021_acs_jafc_8b02524
crossref_primary_10_1007_s13671_012_0017_7
crossref_primary_10_1371_journal_pone_0119872
crossref_primary_10_1007_s12325_022_02241_y
crossref_primary_10_1111_j_1346_8138_2011_01462_x
crossref_primary_10_1080_15321810903405100
crossref_primary_10_1111_1346_8138_17065
crossref_primary_10_1007_s11010_012_1389_5
crossref_primary_10_1111_j_1600_065X_2008_00714_x
crossref_primary_10_1016_j_jaut_2021_102634
crossref_primary_10_1155_2015_819149
crossref_primary_10_1111_imr_12322
crossref_primary_10_1155_2012_718725
crossref_primary_10_1111_j_1365_2133_2008_08769_x
crossref_primary_10_1111_1346_8138_12961
crossref_primary_10_1096_fj_10_172288
crossref_primary_10_1194_jlr_M044305
crossref_primary_10_1097_ACI_0b013e32834a977a
crossref_primary_10_1371_journal_pone_0212043
crossref_primary_10_1016_j_jhep_2010_03_004
crossref_primary_10_1016_j_atherosclerosis_2015_08_006
crossref_primary_10_1186_ar3090
crossref_primary_10_1038_ni_1956
crossref_primary_10_1016_j_intimp_2015_05_030
crossref_primary_10_2217_imt_2018_0028
crossref_primary_10_1016_j_cytogfr_2014_04_005
crossref_primary_10_1016_j_jaci_2010_11_050
crossref_primary_10_1016_j_str_2008_06_005
crossref_primary_10_1007_s11926_014_0414_y
crossref_primary_10_1080_17476348_2016_1174580
crossref_primary_10_1111_sji_12764
crossref_primary_10_1016_j_cellimm_2009_04_005
crossref_primary_10_1002_eji_200939687
crossref_primary_10_3390_ijms19010179
crossref_primary_10_1586_eci_09_64
crossref_primary_10_1111_bjd_14164
crossref_primary_10_1016_j_intimp_2013_02_018
crossref_primary_10_3389_fphar_2017_00125
crossref_primary_10_1111_imr_12027
crossref_primary_10_4049_jimmunol_1801426
crossref_primary_10_4291_wjgp_v7_i1_108
crossref_primary_10_3389_fimmu_2016_00148
crossref_primary_10_1111_cod_12043
crossref_primary_10_1038_icb_2009_68
crossref_primary_10_1038_ni_2025
crossref_primary_10_1111_ijd_12808
crossref_primary_10_1186_s40364_022_00382_4
crossref_primary_10_1096_fj_202101800R
crossref_primary_10_1007_s00281_009_0188_x
crossref_primary_10_1016_j_jdermsci_2013_04_002
crossref_primary_10_1016_j_intimp_2020_106439
crossref_primary_10_4049_jimmunol_1400205
crossref_primary_10_1038_labinvest_2011_76
crossref_primary_10_1002_eji_201546216
crossref_primary_10_1042_CS20110496
crossref_primary_10_1016_j_ajpath_2012_11_030
crossref_primary_10_1111_imm_12871
crossref_primary_10_1016_j_pan_2014_08_005
crossref_primary_10_1146_annurev_immunol_032414_112123
crossref_primary_10_1038_ni_1767
crossref_primary_10_1586_1744666X_2015_1023295
crossref_primary_10_1038_cmi_2012_15
crossref_primary_10_1016_j_jaut_2022_102916
crossref_primary_10_1051_medsci_201026112
crossref_primary_10_3892_ijo_2012_1594
crossref_primary_10_1111_dth_14209
crossref_primary_10_1155_2019_6276254
crossref_primary_10_1016_j_jconrel_2018_05_040
crossref_primary_10_1111_bjh_12616
crossref_primary_10_1038_ni_1770
crossref_primary_10_3892_mmr_2017_6942
crossref_primary_10_1007_s12016_012_8306_2
crossref_primary_10_1111_1346_8138_12248
crossref_primary_10_1007_s00005_018_0527_5
crossref_primary_10_4049_jimmunol_1700021
crossref_primary_10_3389_fimmu_2020_606489
crossref_primary_10_1016_j_jid_2016_12_023
crossref_primary_10_1002_eji_202149485
crossref_primary_10_1111_j_1365_2567_2009_03240_x
crossref_primary_10_1111_dth_12160
crossref_primary_10_1038_s41598_017_13858_3
crossref_primary_10_1146_annurev_immunol_031210_101312
crossref_primary_10_4049_jimmunol_1300575
Cites_doi 10.1189/jlb.0704409
10.1002/eji.200535503
10.4049/jimmunol.168.11.5397
10.1093/hmg/10.17.1793
10.4049/jimmunol.166.12.7096
10.1074/jbc.M007837200
10.1016/j.intimp.2004.01.008
10.1073/pnas.171303198
10.1038/nri1689
10.4049/jimmunol.178.7.4615
10.1186/gb-2002-3-7-research0034
10.1172/JCI1476
10.1074/jbc.M204204200
10.1074/jbc.M005304200
10.1089/107999001317205178
10.1016/j.it.2006.12.005
10.1073/pnas.170291697
10.1046/j.1523-1747.2001.01248.x
10.1177/002215540305100513
10.4049/jimmunol.164.4.1814
10.1016/j.it.2004.03.006
10.1111/1523-1747.ep12371752
10.1016/j.immuni.2004.07.007
10.1016/1043-4666(90)90045-U
10.1038/nature05505
10.4049/jimmunol.174.6.3695
10.1111/1523-1747.ep12371679
10.1084/jem.20061308
10.1007/s00403-004-0460-9
10.1038/ni1497
10.1016/S0022-1759(03)00010-3
10.1111/j.1365-2133.2005.06800.x
10.1001/archderm.135.2.187
10.1016/j.coi.2006.03.017
10.4049/jimmunol.166.12.7090
10.4049/jimmunol.173.3.2151
10.1038/nm0307-242
ContentType Journal Article
Copyright 2008 INIST-CNRS
Distributed under a Creative Commons Attribution 4.0 International License
2007 British Society for Immunology 2007
Copyright_xml – notice: 2008 INIST-CNRS
– notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: 2007 British Society for Immunology 2007
DBID FBQ
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7S9
L.6
7X8
1XC
5PM
DOI 10.1111/j.1365-2249.2007.03511.x
DatabaseName AGRIS
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList AGRICOLA
MEDLINE - Academic


AIDS and Cancer Research Abstracts
MEDLINE
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1365-2249
EndPage 415
ExternalDocumentID PMC2219373
oai_HAL_hal_01705160v1
17900301
19869088
10_1111_j_1365_2249_2007_03511_x
CEI3511
US201300825184
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
169
29B
2WC
31~
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
5WD
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AABZA
AACZT
AAESR
AAEVG
AAHHS
AAONW
AAPXW
AARHZ
AAUAY
AAVAP
AAZKR
ABCQN
ABCUV
ABDBF
ABDFA
ABEJV
ABEML
ABGNP
ABJNI
ABLJU
ABNHQ
ABOCM
ABPTD
ABPVW
ABQNK
ABVGC
ABXVV
ACAHQ
ACCFJ
ACFBH
ACGFO
ACGFS
ACMXC
ACPOU
ACPRK
ACSCC
ACUFI
ACUHS
ACVCV
ACXQS
ADBBV
ADEOM
ADIPN
ADIYS
ADIZJ
ADKYN
ADMGS
ADOZA
ADQBN
ADVEK
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIMD
AEMQT
AENEX
AEQDE
AFBPY
AFEBI
AFFQV
AFFZL
AFGKR
AFRAH
AFTUV
AFXAL
AFZJQ
AGMDO
AGUTN
AHMMS
AIACR
AIAGR
AIURR
AIWBW
AJAOE
AJBDE
AJDVS
AJEEA
AJNCP
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALXQX
AMBMR
AMYDB
AOIJS
ATGXG
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BCRHZ
BEYMZ
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EAS
EBB
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FBQ
FUBAC
G-S
G.N
GODZA
GX1
H.X
H13
HF~
HZI
HZ~
IH2
IHE
IX1
J0M
J5H
K48
KBUDW
KBYEO
KOP
KSI
KSN
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NOMLY
NU-
O66
O9-
OAUYM
OBS
OCZFY
OHT
OIG
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
Q~Q
R.K
ROL
ROX
RPM
RX1
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WVDHM
WXI
X7M
XG1
Y6R
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
1OC
24P
33P
AEUQT
AFPWT
FIJ
IPNFZ
WIN
WRC
AAFWJ
AAYXX
AGORE
AJBYB
CITATION
AAMMB
AEFGJ
AGXDD
AHGBF
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7S9
L.6
7X8
1XC
5PM
ID FETCH-LOGICAL-c6221-591ece163d15b9b1dfa4b7165ad816ad5aa0c841de64eb19579fc24ef5c24ce03
IEDL.DBID DR2
ISSN 0009-9104
1365-2249
IngestDate Thu Aug 21 14:16:15 EDT 2025
Fri May 09 12:18:28 EDT 2025
Fri Jul 11 11:53:06 EDT 2025
Fri Jul 11 09:24:55 EDT 2025
Fri Jul 11 10:10:38 EDT 2025
Thu Apr 03 07:09:35 EDT 2025
Mon Jul 21 09:11:10 EDT 2025
Tue Jul 01 03:52:25 EDT 2025
Thu Apr 24 23:05:43 EDT 2025
Wed Jan 22 16:23:24 EST 2025
Thu Apr 03 09:44:37 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Skin disease
Psoriasis
Cytokine
T-Lymphocyte
Interleukin 22
Biochemistry
Inflammation
Skin
cytokines
Biophysics
Molecular biology
T cells
Language English
License https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
CC BY 4.0
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6221-591ece163d15b9b1dfa4b7165ad816ad5aa0c841de64eb19579fc24ef5c24ce03
Notes http://dx.doi.org/10.1111/j.1365-2249.2007.03511.x
These authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7454-1836
0000-0003-3812-9304
0000-0002-8463-3977
0000-0003-3990-5213
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/2219373
PMID 17900301
PQID 20502764
PQPubID 23462
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2219373
hal_primary_oai_HAL_hal_01705160v1
proquest_miscellaneous_68503256
proquest_miscellaneous_47491629
proquest_miscellaneous_20502764
pubmed_primary_17900301
pascalfrancis_primary_19869088
crossref_citationtrail_10_1111_j_1365_2249_2007_03511_x
crossref_primary_10_1111_j_1365_2249_2007_03511_x
wiley_primary_10_1111_j_1365_2249_2007_03511_x_CEI3511
fao_agris_US201300825184
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2007
PublicationDateYYYYMMDD 2007-12-01
PublicationDate_xml – month: 12
  year: 2007
  text: December 2007
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
PublicationTitle Clinical and experimental immunology
PublicationTitleAlternate Clin Exp Immunol
PublicationYear 2007
Publisher Oxford, UK : Blackwell Publishing Ltd
Blackwell Publishing Ltd
Blackwell
Wiley
Blackwell Science Inc
Publisher_xml – name: Oxford, UK : Blackwell Publishing Ltd
– name: Blackwell Publishing Ltd
– name: Blackwell
– name: Wiley
– name: Blackwell Science Inc
References 2004; 21
2001; 166
2007; 445
2005; 174
2005; 153
2004; 25
2006; 36
2002; 277
2004; 4
2002; 3
2006; 18
2000; 275
2003; 51
2007; 13
2003; 275
1993; 101
2001; 21
2007; 28
2001; 276
1990; 2
1994; 102
2007; 178
2001
2002; 168
2004; 295
2004; 173
2000; 97
2005; 5
2007; 8
2000; 164
1999; 135
2006; 203
2005; 16
1998; 101
2005; 77
2001; 98
2001; 116
2001; 10
Trickett (2022010406282747500_b26) 2003; 275
Xu (2022010406282747500_b19) 2001; 98
Broome (2022010406282747500_b20) 2003; 51
Asadullah (2022010406282747500_b30) 1999; 135
Dumoutier (2022010406282747500_b12) 2000; 164
Dumoutier (2022010406282747500_b7) 2000; 97
Kotenko (2022010406282747500_b18) 2001; 166
Boniface (2022010406282747500_b10) 2005; 174
Boyman (2022010406282747500_b3) 2007; 28
Schlaak (2022010406282747500_b5) 1994; 102
Yssel (2022010406282747500_b25) 2001
Boniface (2022010406282747500_b27) 2005; 16
Asadullah (2022010406282747500_b29) 1998; 101
Wilson (2022010406282747500_b38) 2007; 8
Dumoutier (2022010406282747500_b17) 2001; 166
Uyemura (2022010406282747500_b6) 1993; 101
Otkjaer (2022010406282747500_b36) 2005; 153
Kotenko (2022010406282747500_b15) 2001; 276
Harder (2022010406282747500_b33) 2005; 77
Lejeune (2022010406282747500_b16) 2002; 277
Vandesompele (2022010406282747500_b28) 2002; 3
Harrington (2022010406282747500_b39) 2006; 18
Wolk (2022010406282747500_b13) 2002; 168
Piskin (2022010406282747500_b37) 2004; 295
Lew (2022010406282747500_b1) 2004; 25
Xie (2022010406282747500_b14) 2000; 275
Schaerli (2022010406282747500_b21) 2004; 173
Nagalakshmi (2022010406282747500_b9) 2004; 4
Boniface (2022010406282747500_b4) 2007; 178
Aggarwal (2022010406282747500_b8) 2001; 21
Nickoloff (2022010406282747500_b34) 2007; 13
Bowcock (2022010406282747500_b32) 2001; 10
Bowcock (2022010406282747500_b22) 2005; 5
Wolk (2022010406282747500_b11) 2004; 21
Zheng (2022010406282747500_b24) 2007; 445
Gearing (2022010406282747500_b2) 1990; 2
Reich (2022010406282747500_b31) 2001; 116
Wolk (2022010406282747500_b35) 2006; 36
Liang (2022010406282747500_b23) 2006; 203
References_xml – volume: 28
  start-page: 51
  year: 2007
  end-page: 7
  article-title: The pathogenic role of tissue‐resident immune cells in psoriasis
  publication-title: Trends Immunol
– start-page: 7
  year: 2001
  end-page: 19
– volume: 275
  start-page: 251
  year: 2003
  end-page: 5
  article-title: T cell stimulation and expansion using anti‐CD3/CD28 beads
  publication-title: J Immunol Methods
– volume: 10
  start-page: 1793
  year: 2001
  end-page: 805
  article-title: Insights into psoriasis and other inflammatory diseases from large‐scale gene expression studies
  publication-title: Hum Mol Genet
– volume: 21
  start-page: 1047
  year: 2001
  end-page: 53
  article-title: Acinar cells of the pancreas are a target of interleukin‐22
  publication-title: J Interferon Cytokine Res
– volume: 3
  start-page: 1
  year: 2002
  end-page: 12
  article-title: Accurate normalization of real‐time quantitative RT–PCR data by geometric averaging of multiple internal control genes
  publication-title: Genome Biol
– volume: 174
  start-page: 3695
  year: 2005
  end-page: 702
  article-title: IL‐22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes
  publication-title: J Immunol
– volume: 153
  start-page: 911
  year: 2005
  end-page: 18
  article-title: The dynamics of gene expression of interleukin‐19 and interleukin‐20 and their receptors in psoriasis
  publication-title: Br J Dermatol
– volume: 18
  start-page: 349
  year: 2006
  end-page: 56
  article-title: Expanding the effector CD4 T‐cell repertoire: the Th17 lineage
  publication-title: Curr Opin Immunol
– volume: 166
  start-page: 7090
  year: 2001
  end-page: 5
  article-title: Cloning and characterization of IL‐22 binding protein, a natural antagonist of IL‐10‐related T cell‐derived inducible factor/IL‐22
  publication-title: J Immunol
– volume: 2
  start-page: 68
  year: 1990
  end-page: 75
  article-title: Cytokines in skin lesions of psoriasis
  publication-title: Cytokine
– volume: 101
  start-page: 783
  year: 1998
  end-page: 94
  article-title: IL‐10 is a key cytokine in psoriasis. Proof of principle by IL‐10 therapy: a new therapeutic approach
  publication-title: J Clin Invest
– volume: 166
  start-page: 7096
  year: 2001
  end-page: 103
  article-title: Identification, cloning, and characterization of a novel soluble receptor that binds IL‐22 and neutralizes its activity
  publication-title: J Immunol
– volume: 5
  start-page: 699
  year: 2005
  end-page: 711
  article-title: Getting under the skin: the immunogenetics of psoriasis
  publication-title: Nat Rev Immunol
– volume: 97
  start-page: 10144
  year: 2000
  end-page: 9
  article-title: Human interleukin‐10‐related T cell‐derived inducible factor: molecular cloning and functional characterization as an hepatocyte‐stimulating factor
  publication-title: Proc Natl Acad Sci USA
– volume: 173
  start-page: 2151
  year: 2004
  end-page: 8
  article-title: Characterization of human T cells that regulate neutrophilic skin inflammation
  publication-title: J Immunol
– volume: 4
  start-page: 679
  year: 2004
  end-page: 91
  article-title: Interleukin‐22 activates STAT3 and induces IL‐10 by colon epithelial cells
  publication-title: Int Immunopharmacol
– volume: 445
  start-page: 648
  year: 2007
  end-page: 51
  article-title: Interleukin‐22, a TH17 cytokine, mediates IL‐23‐induced dermal inflammation and acanthosis
  publication-title: Nature
– volume: 275
  start-page: 31335
  year: 2000
  end-page: 9
  article-title: Interleukin (IL)‐22, a novel human cytokine that signals through the interferon receptor‐related proteins CRF2‐4 and IL‐22R
  publication-title: J Biol Chem
– volume: 164
  start-page: 1814
  year: 2000
  end-page: 19
  article-title: Cloning and characterization of IL‐10‐related T cell‐derived inducible factor (IL‐TIF), a novel cytokine structurally related to IL‐10 and inducible by IL‐9
  publication-title: J Immunol
– volume: 277
  start-page: 33676
  year: 2002
  end-page: 82
  article-title: Interleukin‐22 (IL‐22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL‐10
  publication-title: J Biol Chem
– volume: 295
  start-page: 509
  year: 2004
  end-page: 16
  article-title: T cells in psoriatic lesional skin that survive conventional therapy with NB‐UVB radiation display reduced IFN‐gamma expression
  publication-title: Arch Dermatol Res
– volume: 135
  start-page: 187
  year: 1999
  end-page: 92
  article-title: Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial
  publication-title: Arch Dermatol
– volume: 116
  start-page: 319
  year: 2001
  end-page: 29
  article-title: Response of psoriasis to interleukin‐10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin‐8/CXCR2 pathway and normalization of keratinocyte maturation
  publication-title: J Invest Dermatol
– volume: 13
  start-page: 242
  year: 2007
  end-page: 4
  article-title: Cracking the cytokine code in psoriasis
  publication-title: Nat Med
– volume: 21
  start-page: 241
  year: 2004
  end-page: 54
  article-title: IL‐22 increases the innate immunity of tissues
  publication-title: Immunity
– volume: 276
  start-page: 2725
  year: 2001
  end-page: 32
  article-title: Identification of the functional interleukin‐22 (IL‐22) receptor complex: the IL‐10R2 chain (IL‐10Rbeta) is a common chain of both the IL‐10 and IL‐22 (IL‐10‐related T cell‐derived inducible factor, IL‐TIF) receptor complexes
  publication-title: J Biol Chem
– volume: 101
  start-page: 701
  year: 1993
  end-page: 5
  article-title: The cytokine network in lesional and lesion‐free psoriatic skin is characterized by a T‐helper type 1 cell‐mediated response
  publication-title: J Invest Dermatol
– volume: 25
  start-page: 295
  year: 2004
  end-page: 305
  article-title: Psoriasis vulgaris: cutaneous lymphoid tissue supports T‐cell activation and ‘Type 1’ inflammatory gene expression
  publication-title: Trends Immunol
– volume: 168
  start-page: 5397
  year: 2002
  end-page: 402
  article-title: Cutting edge: immune cells as sources and targets of the IL‐10 family members?
  publication-title: J Immunol
– volume: 102
  start-page: 145
  year: 1994
  end-page: 9
  article-title: T cells involved in psoriasis vulgaris belong to the Th1 subset
  publication-title: J Invest Dermatol
– volume: 51
  start-page: 675
  year: 2003
  end-page: 85
  article-title: S100 protein subcellular localization during epidermal differentiation and psoriasis
  publication-title: J Histochem Cytochem
– volume: 203
  start-page: 2271
  year: 2006
  end-page: 9
  article-title: Interleukin (IL)‐22 and IL‐17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
  publication-title: J Exp Med
– volume: 178
  start-page: 4615
  year: 2007
  end-page: 22
  article-title: Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation
  publication-title: J Immunol
– volume: 98
  start-page: 9511
  year: 2001
  end-page: 16
  article-title: A soluble class II cytokine receptor, IL‐22RA2, is a naturally occurring IL‐22 antagonist
  publication-title: Proc Natl Acad Sci USA
– volume: 16
  start-page: 309
  year: 2005
  end-page: 19
  article-title: Keratinocytes as targets for interleukin‐10‐related cytokines: a putative role in the pathogenesis of psoriasis
  publication-title: Eur Cytokine Netw
– volume: 77
  start-page: 476
  year: 2005
  end-page: 86
  article-title: Psoriatic scales: a promising source for the isolation of human skin‐derived antimicrobial proteins
  publication-title: J Leukoc Biol
– volume: 8
  start-page: 950
  year: 2007
  end-page: 7
  article-title: Development, cytokine profile and function of human interleukin 17‐producing helper T cells
  publication-title: Nat Immunol
– volume: 36
  start-page: 1309
  year: 2006
  end-page: 23
  article-title: IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis
  publication-title: Eur J Immunol
– volume: 77
  start-page: 476
  year: 2005
  ident: 2022010406282747500_b33
  article-title: Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0704409
– volume: 36
  start-page: 1309
  year: 2006
  ident: 2022010406282747500_b35
  article-title: IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200535503
– volume: 168
  start-page: 5397
  year: 2002
  ident: 2022010406282747500_b13
  article-title: Cutting edge: immune cells as sources and targets of the IL-10 family members?
  publication-title: J Immunol
  doi: 10.4049/jimmunol.168.11.5397
– volume: 10
  start-page: 1793
  year: 2001
  ident: 2022010406282747500_b32
  article-title: Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/10.17.1793
– volume: 166
  start-page: 7096
  year: 2001
  ident: 2022010406282747500_b18
  article-title: Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity
  publication-title: J Immunol
  doi: 10.4049/jimmunol.166.12.7096
– volume: 276
  start-page: 2725
  year: 2001
  ident: 2022010406282747500_b15
  article-title: Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M007837200
– volume: 4
  start-page: 679
  year: 2004
  ident: 2022010406282747500_b9
  article-title: Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2004.01.008
– volume: 98
  start-page: 9511
  year: 2001
  ident: 2022010406282747500_b19
  article-title: A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.171303198
– volume: 5
  start-page: 699
  year: 2005
  ident: 2022010406282747500_b22
  article-title: Getting under the skin: the immunogenetics of psoriasis
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1689
– volume: 178
  start-page: 4615
  year: 2007
  ident: 2022010406282747500_b4
  article-title: Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.7.4615
– volume: 3
  start-page: 1
  year: 2002
  ident: 2022010406282747500_b28
  article-title: Accurate normalization of real-time quantitative RT–PCR data by geometric averaging of multiple internal control genes
  publication-title: Genome Biol
  doi: 10.1186/gb-2002-3-7-research0034
– volume: 101
  start-page: 783
  year: 1998
  ident: 2022010406282747500_b29
  article-title: IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach
  publication-title: J Clin Invest
  doi: 10.1172/JCI1476
– volume: 277
  start-page: 33676
  year: 2002
  ident: 2022010406282747500_b16
  article-title: Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M204204200
– volume: 275
  start-page: 31335
  year: 2000
  ident: 2022010406282747500_b14
  article-title: Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M005304200
– volume: 21
  start-page: 1047
  year: 2001
  ident: 2022010406282747500_b8
  article-title: Acinar cells of the pancreas are a target of interleukin-22
  publication-title: J Interferon Cytokine Res
  doi: 10.1089/107999001317205178
– volume: 28
  start-page: 51
  year: 2007
  ident: 2022010406282747500_b3
  article-title: The pathogenic role of tissue-resident immune cells in psoriasis
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2006.12.005
– volume: 97
  start-page: 10144
  year: 2000
  ident: 2022010406282747500_b7
  article-title: Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.170291697
– volume: 116
  start-page: 319
  year: 2001
  ident: 2022010406282747500_b31
  article-title: Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation
  publication-title: J Invest Dermatol
  doi: 10.1046/j.1523-1747.2001.01248.x
– volume: 51
  start-page: 675
  year: 2003
  ident: 2022010406282747500_b20
  article-title: S100 protein subcellular localization during epidermal differentiation and psoriasis
  publication-title: J Histochem Cytochem
  doi: 10.1177/002215540305100513
– volume: 164
  start-page: 1814
  year: 2000
  ident: 2022010406282747500_b12
  article-title: Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9
  publication-title: J Immunol
  doi: 10.4049/jimmunol.164.4.1814
– volume: 16
  start-page: 309
  year: 2005
  ident: 2022010406282747500_b27
  article-title: Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis
  publication-title: Eur Cytokine Netw
– start-page: 7
  volume-title: Current protocols in immunology
  year: 2001
  ident: 2022010406282747500_b25
– volume: 25
  start-page: 295
  year: 2004
  ident: 2022010406282747500_b1
  article-title: Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and ‘Type 1’ inflammatory gene expression
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2004.03.006
– volume: 102
  start-page: 145
  year: 1994
  ident: 2022010406282747500_b5
  article-title: T cells involved in psoriasis vulgaris belong to the Th1 subset
  publication-title: J Invest Dermatol
  doi: 10.1111/1523-1747.ep12371752
– volume: 21
  start-page: 241
  year: 2004
  ident: 2022010406282747500_b11
  article-title: IL-22 increases the innate immunity of tissues
  publication-title: Immunity
  doi: 10.1016/j.immuni.2004.07.007
– volume: 2
  start-page: 68
  year: 1990
  ident: 2022010406282747500_b2
  article-title: Cytokines in skin lesions of psoriasis
  publication-title: Cytokine
  doi: 10.1016/1043-4666(90)90045-U
– volume: 445
  start-page: 648
  year: 2007
  ident: 2022010406282747500_b24
  article-title: Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
  publication-title: Nature
  doi: 10.1038/nature05505
– volume: 174
  start-page: 3695
  year: 2005
  ident: 2022010406282747500_b10
  article-title: IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes
  publication-title: J Immunol
  doi: 10.4049/jimmunol.174.6.3695
– volume: 101
  start-page: 701
  year: 1993
  ident: 2022010406282747500_b6
  article-title: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response
  publication-title: J Invest Dermatol
  doi: 10.1111/1523-1747.ep12371679
– volume: 203
  start-page: 2271
  year: 2006
  ident: 2022010406282747500_b23
  article-title: Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
  publication-title: J Exp Med
  doi: 10.1084/jem.20061308
– volume: 295
  start-page: 509
  year: 2004
  ident: 2022010406282747500_b37
  article-title: T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-gamma expression
  publication-title: Arch Dermatol Res
  doi: 10.1007/s00403-004-0460-9
– volume: 8
  start-page: 950
  year: 2007
  ident: 2022010406282747500_b38
  article-title: Development, cytokine profile and function of human interleukin 17-producing helper T cells
  publication-title: Nat Immunol
  doi: 10.1038/ni1497
– volume: 275
  start-page: 251
  year: 2003
  ident: 2022010406282747500_b26
  article-title: T cell stimulation and expansion using anti-CD3/CD28 beads
  publication-title: J Immunol Methods
  doi: 10.1016/S0022-1759(03)00010-3
– volume: 153
  start-page: 911
  year: 2005
  ident: 2022010406282747500_b36
  article-title: The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2005.06800.x
– volume: 135
  start-page: 187
  year: 1999
  ident: 2022010406282747500_b30
  article-title: Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.135.2.187
– volume: 18
  start-page: 349
  year: 2006
  ident: 2022010406282747500_b39
  article-title: Expanding the effector CD4 T-cell repertoire: the Th17 lineage
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2006.03.017
– volume: 166
  start-page: 7090
  year: 2001
  ident: 2022010406282747500_b17
  article-title: Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22
  publication-title: J Immunol
  doi: 10.4049/jimmunol.166.12.7090
– volume: 173
  start-page: 2151
  year: 2004
  ident: 2022010406282747500_b21
  article-title: Characterization of human T cells that regulate neutrophilic skin inflammation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.3.2151
– volume: 13
  start-page: 242
  year: 2007
  ident: 2022010406282747500_b34
  article-title: Cracking the cytokine code in psoriasis
  publication-title: Nat Med
  doi: 10.1038/nm0307-242
SSID ssj0006662
Score 2.3656368
Snippet Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis,...
Summary Interleukin (IL)‐22 is a T cell‐derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of...
SourceID pubmedcentral
hal
proquest
pubmed
pascalfrancis
crossref
wiley
fao
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 407
SubjectTerms Adaptive immunology
Adult
Aged
Aged, 80 and over
Analytical, structural and metabolic biochemistry
Biochemistry
Biochemistry, Molecular Biology
Biological and medical sciences
biosynthesis
Cells, Cultured
cytokines
Dermatology
Female
Fundamental and applied biological sciences. Psychology
Gene Expression Profiling
Gene Expression Profiling - methods
genetics
Human health and pathology
Humans
Immunology
inflammation
Inflammation Mediators
Inflammation Mediators - metabolism
Innate immunity
Interleukin-22
Interleukins
Interleukins - biosynthesis
Interleukins - genetics
Interleukins - immunology
Keratinocytes
Keratinocytes - immunology
Life Sciences
Male
metabolism
methods
Middle Aged
Molecular and cellular biology
Molecular biophysics
psoriasis
Psoriasis - immunology
Receptors, Interleukin
Receptors, Interleukin - metabolism
Reverse Transcriptase Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction - methods
RNA, Messenger
RNA, Messenger - genetics
Skin
Skin - immunology
skin disease
T cells
T-lymphocytes
T-Lymphocytes - immunology
Translational Studies
Up-Regulation
Title role for T cell-derived interleukin 22 in psoriatic skin inflammation
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2249.2007.03511.x
https://www.ncbi.nlm.nih.gov/pubmed/17900301
https://www.proquest.com/docview/20502764
https://www.proquest.com/docview/47491629
https://www.proquest.com/docview/68503256
https://univ-poitiers.hal.science/hal-01705160
https://pubmed.ncbi.nlm.nih.gov/PMC2219373
Volume 150
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BJRAS4lEeDY9iIa5ZxY6dbI6rqmWLKAfoSnuznNhpq62yq81uBZz4CfxGfgkzTna3gVaqEBcrLzvJ-LP9TWYyA_DOoLaGq4QLEUBxKBOjwlxGLoyRnWRRYdLUW3SPPiXDkfwwVuPW_4n-hWniQ6w_uNHI8PM1DXCT191B7j20UH9oIxGSTaxHfJJOED_6vIkkhSxdrJKq4Qopu049VzbUWalul2aK5Sl5S96fmRoFWDaZL66ipn97WF5mvn7pOngIk9VLNx4rk95ykfeK73_Eg_w_UnkED1qGywYNJB_DLVdtw50m5-W3bbh71Frzn8DhgJFzI0PezI4ZmRB-_fhpcUhcOMsojsX83C0nZxUTAnfZrJ7OCUgFq-kgDg1Ec_Pn5VMYHewf7w3DNrVDWCRC8FBl3BUOuaDlKs9ybksjc1TdlLF9nhirjImKvuTWJRJXE7IlloWQrlRYUoqzZ7BVTSu3A0whwUpdnNpMFjIrsWXjpJGR5WVuRZkHkK66URdt3HNKv3GuL-k_KDNNMqOsnKn2MtNfA-DrmrMm9scN6uwgUrQ5wSlaj74IMgyTFo6KdABvET7rliiu93DwUdMxH9SIJ9EFD2C3g67NjTPKHdbvB_BmBTeNMwH1jancdFnjY6hIpIm8_gqZStQGRHb9FUlfRTGy4ACeNwDe3D_NvPqM4uxAu_M-3TPV2amPV44djn0UB5B45N5Ylnpv_5C2XvxrxZdwz3-K995Hr2BrMV-618ghF_munx2wfD_mvwEK1F-a
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61RTwkxKMFah7tCsHRkb1evw4coj6U0KQHSKTelrW9plUrJ8qjtJz4Cfwf_gonfgkzayepoZUqpB64WIkfa3tnvt2ZnfE3AG8Uems4S2gbFcizRaB8OxGOtj20TmInVWFoIrrd_aDVF-8P_IMl-DH7Fqbkh5gvuBEyzHhNAKcF6TrKTYoWOhAVFSEFxRpnVYblnj7_gv7b-F17G4X9lvPdnd5Wy65KDNhpwLlr-7GrU402Seb6SZy4Wa5Egi6Er7LIDVTmK-WkkXAzHQgc1Simladc6NzHLZXawnaX4RYVFCfi_u0PC-4q9Av4rIwbzsminkZ06ZPX5sblXA1we0j5mfeHaowiy8taG5cZw3_ndF60tc1kufsQfs66ucyROW5MJ0kj_foHA-V_KodH8KAy4lmzRN1jWNLFKtwuy3qer8KdbpWwsAbtJqP8TYauAesxipL8-vY9Q9Sf6owRVcfoRE-PjwrGOf5lw_FgRFhJ2Zh2IvoRsOXHpU-gfyOv9BRWikGh14H5aEOG2guzWKQizrFlpYUSTubmScbzxIJwpjcyrajdqcLIibzg4qGMJMmICo-G0shInlngzq8clvQm17hmHVVTqs84C8n-R06xb1pocCNhwWvU13lLRF3eanYk7TO8TW7gnLoWbNTUeXHjmMqjRZEFmzP9ljjYkWxUoQfTMT6G7_AwEFefIUKBDg-Prz4jiHzHQ0PfgmclYhb3D2OzQoDdWcNS7X3qR4qjQ0PJjgJHGXkWBAYq1-5LubXTpl_P__XCTbjb6nU7stPe33sB90zkwSRbvYSVyWiqX6HJPEk2zNDE4NNNY_A3fWC9-Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61RVRIiEd51DxaC8HRkXezfh04RG2jhD6EoJF6W9beNa1aOVEepeXET-D38Fe48UuYWTtJDa1UIfXAxUps79q7M9_OzM54BuC1QmsNpYTxkIGanghV4KXCN14TtZPEz1QUWY_u7l7Y6Yl3B8HBAvyYfgtT5oeYbbgRMux6TQAf6LwOchuhhfZDlYmQfGKNsyrActucf0HzbfS2u4m0fsN5e2t_o-NVFQa8LOSceUHCTGZQJdEsSJOU6VyJFC2IQOmYhUoHSvlZLJg2ocBFjVxaecaFyQM8UqUt7HcRbokQx0UK2Yd56io0C_i0ihuKZFGPIrr0zWuicTFXfTweUnjm3YEaIcXystTGZbrw3yGdF1VtKyvb9-HndJbLEJnjxmScNrKvfySg_D_J8ADuVSq82yox9xAWTLECt8uinucrsLxbhSs8gm7LpehNFw0Dd98lH8mvb981Yv7UaJcSdQxPzOT4qHA5x7_uYNQfElIyd0QnEfsI1_LT0sfQu5EhPYGlol-YVXAD1CAj04x0IjKR5NizMkIJX7M81TxPHYimbCOzKrE71Rc5kRcMPKSRJBpR2dFIWhrJMwfYrOWgTG5yjTaryJlSfUYZJHsfOXm-aZuBxcKBV8ius54ocXmntSPpnM3axEL_lDmwVuPm-YMTKo4Wxw6sT9lb4lJHtFGF6U9G-BqBz6NQXH2HiASaOzy5-o4wDvwmqvkOPC0BM39-lNj9AZzOGpRq46lfKY4ObUJ2JDjSqOlAaJFy7bmUG1td-vXsXxuuw_L7zbbc6e5tP4c71u1gI61ewNJ4ODEvUV8ep2t2YXLh001D8DdoT7yo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+role+for+T+cell-derived+interleukin+22+in+psoriatic+skin+inflammation&rft.jtitle=Clinical+and+experimental+immunology&rft.au=Boniface%2C+Katia&rft.au=Guignouard%2C+Emmanuel&rft.au=Pedretti%2C+Nathalie&rft.au=Garcia%2C+Martine&rft.date=2007-12-01&rft.pub=Wiley&rft.issn=0009-9104&rft.eissn=1365-2249&rft.volume=150&rft.issue=3&rft.spage=407&rft.epage=415&rft_id=info:doi/10.1111%2Fj.1365-2249.2007.03511.x&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_01705160v1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-9104&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-9104&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-9104&client=summon